EIR BioReliance Sep 2017

Xiaoping Guan FDA, Carla Lundi FDA$595.00 - Available Now

FDA investigators audited the BioReliance - Glasgow, United Kingdom facility and issued inspectional observation (via FDA 483) on 22 Sep 2017.

Product details

  • Category:
  • Inspection end: 22 Sep 2017
  • Location: Glasgow, United Kingdom
  • FEI: 3005343934
Add To Cart